Clinical Trial Update: A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 randomized trial comparing quilizumab to placebo in patients with refractory chronic spontaneous urticaria. It…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• Quilizumab (quilizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Urticaria | Phase 2 | Status: COMPLETED